메뉴 건너뛰기




Volumn 57, Issue 1, 2002, Pages 39-43

Clinical use of Levofloxacin in the long term treatment of drug resistant tuberculosis

Author keywords

Levofloxacin; Long term; Multidrug resistant; Tuberculosis

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; CAPREOMYCIN; CIPROFLOXACIN; CLOFAZIMINE; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; TERIZIDONE; TUBERCULOSTATIC AGENT;

EID: 14244270463     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (30)

References (22)
  • 17
    • 0032487052 scopus 로고    scopus 로고
    • Community based approaches to the control of multidrug resistant tuberculosis: Introducing "DOTS-plus"
    • (1998) BMJ , vol.317 , pp. 671-674
    • Farmer, P.1    Kim, J.Y.2
  • 19
  • 21
    • 0032706182 scopus 로고    scopus 로고
    • Activity of quinolones against mycobacteria
    • (1999) Drugs , vol.58 , Issue.SUPPL. 2 , pp. 19-22
    • Jacobs, M.R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.